Zynerba Pharmaceuticals Depreciation & Amortization 2011-2025 | ZYNE

Annual Depreciation & Amortization Zynerba Pharmaceuticals

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
219 K	247 K	207 K	134 K	99.6 K	94.2 K	75.3 K	26 K	27.1 K	49.4 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
247 K	26 K	118 K

Quarterly Depreciation & Amortization Zynerba Pharmaceuticals

2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	51.6 K	-	166 K	115 K	60.7 K	-	185 K	123 K	61.5 K	-	57.8 K	48.2 K	41.2 K	-	36 K	32.9 K	29.3 K	-	25 K	21.6 K	26.6 K	-	24.8 K	23.2 K	20.4 K	-	25.8 K	13.9 K	13.6 K	-	8.23 K	3.1 K	1.45 K	-	6.85 K	9.13 K	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
185 K	1.45 K	45.6 K

Depreciation & Amortization of other stocks in the Drug manufacturers industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Alimera Sciences ALIM	8.75 M	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	6.4 M	-	-	$ 754 M	USA
Canopy Growth Corporation CGC	21.5 M	$ 1.21	1.68 %	$ 130 M	Canada
AcelRx Pharmaceuticals ACRX	311 K	-	7.5 %	$ 6.35 M	USA
Adamis Pharmaceuticals Corporation ADMP	1.48 M	-	0.86 %	$ 117 M	USA
Catalent CTLT	489 M	-	-	$ 11.5 B	USA
Agile Therapeutics AGRX	102 K	-	10.11 %	$ 58.2 M	USA
DURECT Corporation DRRX	31 K	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	646 K	-	-39.89 %	$ 27.7 M	USA
Endo International plc ENDP	306 M	-	-	$ 28.9 M	Irlanda
Zomedica Corp. ZOM	830 K	-	-0.21 %	$ 98 M	USA
Emergent BioSolutions EBS	125 M	$ 12.29	-1.09 %	$ 629 M	USA
Athenex ATNX	4.47 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	2.68 M	$ 21.57	-0.12 %	$ 2.05 B	France
Evolus EOLS	5.3 M	$ 6.66	-3.55 %	$ 413 M	USA
Harrow Health HROW	1.06 M	$ 50.7	1.22 %	$ 1.65 B	USA
China Pharma Holdings CPHI	2.62 M	$ 1.27	-1.32 %	$ 22.2 M	China
Neoleukin Therapeutics NLTX	3.26 M	-	-	$ 193 M	Canada
Organogenesis Holdings ORGO	13.6 M	$ 5.19	-1.71 %	$ 683 M	USA
Bausch Health Companies BHC	1.26 B	$ 7.16	-0.56 %	$ 2.61 B	Canada
Lannett Company LCI	34.3 M	-	1.15 %	$ 7.11 M	USA
Sonoma Pharmaceuticals SNOA	138 K	$ 3.66	0.83 %	$ 4.54 M	USA
Cumberland Pharmaceuticals CPIX	4.9 M	$ 4.01	-2.55 %	$ 56.4 M	USA
Rockwell Medical RMTI	1.44 M	$ 0.8	-7.01 %	$ 18.7 M	USA
Pacira BioSciences PCRX	78.8 M	$ 26.17	-1.3 %	$ 1.21 B	USA
PetIQ PETQ	44.5 M	-	1.64 %	$ 400 M	USA
Jupiter Wellness JUPW	429 K	-	-	$ 33.6 M	USA
Veru VERU	268 K	$ 2.22	-7.71 %	$ 299 M	USA
Perrigo Company plc PRGO	326 M	$ 13.94	0.87 %	$ 1.92 B	USA
ProPhase Labs PRPH	4.72 M	$ 0.45	-14.17 %	$ 7.13 M	USA
Radius Health RDUS	1.16 M	-	-	$ 1.42 B	USA
cbdMD YCBD	452 K	$ 1.43	-15.88 %	$ 6.17 M	USA
Recro Pharma REPH	8.22 M	-	-4.76 %	$ 65.3 M	USA
Relmada Therapeutics RLMD	1.26 K	$ 4.43	-1.77 %	$ 133 M	USA
OptiNose OPTN	402 K	-	-	$ 1.08 B	USA
Assertio Holdings ASRT	28.2 M	$ 9.56	-3.82 %	$ 679 M	USA
PLx Pharma PLXP	116 K	-	-27.8 %	$ 2.56 M	USA
Solid Biosciences SLDB	2.46 M	$ 5.63	-3.68 %	$ 230 M	USA
SCYNEXIS SCYX	580 K	$ 0.63	6.75 %	$ 30.1 M	USA
Tricida TCDA	442 K	-	-	$ 3.25 M	USA
Tilray TLRY	35.7 M	$ 9.32	-2.87 %	$ 5.76 B	Canada
TherapeuticsMD TXMD	922 K	$ 1.68	-3.43 %	$ 17.5 M	USA